Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses
A. A. Ordonez, C. K. Bullen, A. F. Villabona-Rueda, E. A. Thompson, M. L. Turner, S. L. Davis, O. Komm, J. D. Powell, F. R. D'Alessio, R. H. Yolken, S. K. Jain, L. Jones-Brando
This study shows sulforaphane inhibits SARS-CoV-2 and HCoV-OC43 replication in vitro and reduces viral load and lung injury in mice.
bioRxiv · Mar 25, 2021Microbiology